Literature DB >> 31489302

Perioperative impact of liver venous deprivation compared with portal venous embolization in patients undergoing right hepatectomy: preliminary results from the pioneer center.

Fabrizio Panaro1, Fabio Giannone1, Benjamin Riviere2, Olivia Sgarbura3, Caterina Cusumano3, Emmanuel Deshayes4, Francis Navarro1, Boris Guiu5, Francois Quenet3.   

Abstract

BACKGROUND: Preoperative portal vein embolization (PVE) is currently the standard technique used routinely to increase the size of the future remnant liver (FRL) before major hepatectomies. The degree of hypertrophy (DH) is approximatively 10% and requires on average six weeks. ALPPS is faster and achieves a good DH but with a higher morbidity and mortality. One method recently proposed to increase the FRL is liver venous deprivation (LVD), but its clinical and operative impact is still unknown. The aim of this study is to compare intra- and postoperative morbidity/mortality and the histological evaluation of the liver parenchyma between PVE and LVD in patients undergoing anatomic right hepatectomy.
METHODS: Fifty-three consecutive patients undergoing PVE and LVD before a major hepatectomy were retrospectively analysed between 2015 and 2017. In order to reduce the bias, only potential standard right hepatectomies were selected. Surgical resections and the radiologic procedures were performed by the same Institution. Intra-operative parameters (transfusions, perfusions, bleeding, operative time), postoperative complications (Clavien-Dindo and ISGLS criteria), and histological findings were compared.
RESULTS: To induce FRL growth 16 patients underwent PVE and 13 LVD. One patient of the PVE group was not resected due to peritoneal metastases. Surgery was performed for hepatocellular carcinoma (PVE =9, LVD =3), metastases (PVE =5, LVD =10), or others diseases (PVE =2, LVD =0). Per- and post-operative morbidity/mortality rates after PVE and LVD procedures were null. No differences between the two groups were found in terms of intraoperative bleeding (median: 550 vs. 1,200 mL; P=0.36), hepatic pedicle clamping (5 vs. 3 patients; P=0.69), intraoperative red blood cells transfusions (median: 622 vs. 594; P=0.42) and operative time (median: 270 vs. 330 min; P=0.34). Post-operative course was similar when comparing both medical and surgical complications in the two arms (PVE n=7, LVD n=10, P=0.1). Major complications (Clavien-Dindo ≥ IIIa) occurred in 3 patients undergoing PVE and in 1 patient of the LVD group (P=0.6). No difference in biliary leak (P=0.1), haemorrhage (P=0.2) and liver failure (P=0.64) was found. One cirrhotic patient in the group of PVE died of post-operative liver failure due to left portal vein thrombosis. Although we experienced a more marked liver damage when assessing on neoplastic liver parenchyma, no statistical difference was observed in terms of atrophy (P=0.19), necrosis (P=0.5), hemorrhage (P=0.42) and sinusoidal dilatation (P=0.69).
CONCLUSIONS: Despite the limitations of our study, to our knowledge this is the first report to compare the two techniques LVD is a promising and safe procedure to induce a fast FRL hypertrophy, showing similar mortality/morbidity rates during and after surgery compared to PVE.

Entities:  

Keywords:  Liver venous deprivation (LVD); hepatectomy; liver failure; portal embolization

Year:  2019        PMID: 31489302      PMCID: PMC6700017          DOI: 10.21037/hbsn.2019.07.06

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN: 2304-3881            Impact factor:   7.293


  32 in total

1.  Analysis of intrahepatic venovenous shunt by hepatic venography.

Authors:  Takanori Sakaguchi; Shohachi Suzuki; Keisuke Inaba; Kazuhiko Fukumoto; Yasuo Takehara; Hatsuko Nasu; Mika Kamiya; Shuhei Yamashita; Takasuke Ushio; Satoshi Nakamura; Hiroyuki Konno
Journal:  Surgery       Date:  2010-06       Impact factor: 3.982

2.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  Lancet       Date:  2007-10-20       Impact factor: 79.321

3.  Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome.

Authors:  D Ribero; E K Abdalla; D C Madoff; M Donadon; E M Loyer; J-N Vauthey
Journal:  Br J Surg       Date:  2007-11       Impact factor: 6.939

Review 4.  Interventional oncology: new options for interstitial treatments and intravascular approaches: right hepatic vein embolization after right portal vein embolization for inducing hypertrophy of the future liver remnant.

Authors:  Gi-Young Ko; Shin Hwang; Kyu-Bo Sung; Dong-Il Gwon; Sung-Gyu Lee
Journal:  J Hepatobiliary Pancreat Sci       Date:  2009-11-05       Impact factor: 7.027

5.  Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS).

Authors:  Nuh N Rahbari; O James Garden; Robert Padbury; Mark Brooke-Smith; Michael Crawford; Rene Adam; Moritz Koch; Masatoshi Makuuchi; Ronald P Dematteo; Christopher Christophi; Simon Banting; Val Usatoff; Masato Nagino; Guy Maddern; Thomas J Hugh; Jean-Nicolas Vauthey; Paul Greig; Myrddin Rees; Yukihiro Yokoyama; Sheung Tat Fan; Yuji Nimura; Joan Figueras; Lorenzo Capussotti; Markus W Büchler; Jürgen Weitz
Journal:  Surgery       Date:  2011-01-14       Impact factor: 3.982

Review 6.  Post-hepatectomy haemorrhage: a definition and grading by the International Study Group of Liver Surgery (ISGLS).

Authors:  Nuh N Rahbari; O James Garden; Robert Padbury; Guy Maddern; Moritz Koch; Thomas J Hugh; Sheung Tat Fan; Yuji Nimura; Joan Figueras; Jean-Nicolas Vauthey; Myrddin Rees; Rene Adam; Ronald P Dematteo; Paul Greig; Val Usatoff; Simon Banting; Masato Nagino; Lorenzo Capussotti; Yukihiro Yokoyama; Mark Brooke-Smith; Michael Crawford; Christopher Christophi; Masatoshi Makuuchi; Markus W Büchler; Jürgen Weitz
Journal:  HPB (Oxford)       Date:  2011-06-07       Impact factor: 3.647

7.  Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery.

Authors:  Moritz Koch; O James Garden; Robert Padbury; Nuh N Rahbari; Rene Adam; Lorenzo Capussotti; Sheung Tat Fan; Yukihiro Yokoyama; Michael Crawford; Masatoshi Makuuchi; Christopher Christophi; Simon Banting; Mark Brooke-Smith; Val Usatoff; Masato Nagino; Guy Maddern; Thomas J Hugh; Jean-Nicolas Vauthey; Paul Greig; Myrddin Rees; Yuji Nimura; Joan Figueras; Ronald P DeMatteo; Markus W Büchler; Jürgen Weitz
Journal:  Surgery       Date:  2011-02-12       Impact factor: 3.982

8.  Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings.

Authors:  Andreas A Schnitzbauer; Sven A Lang; Holger Goessmann; Silvio Nadalin; Janine Baumgart; Stefan A Farkas; Stefan Fichtner-Feigl; Thomas Lorf; Armin Goralcyk; Rüdiger Hörbelt; Alexander Kroemer; Martin Loss; Petra Rümmele; Marcus N Scherer; Winfried Padberg; Alfred Königsrainer; Hauke Lang; Aiman Obed; Hans J Schlitt
Journal:  Ann Surg       Date:  2012-03       Impact factor: 12.969

9.  Sequential preoperative ipsilateral hepatic vein embolization after portal vein embolization to induce further liver regeneration in patients with hepatobiliary malignancy.

Authors:  Shin Hwang; Sung-Gyu Lee; Gi-Young Ko; Bum-Soo Kim; Kyu-Bo Sung; Myung-Hwan Kim; Sung-Koo Lee; Hea-Nam Hong
Journal:  Ann Surg       Date:  2009-04       Impact factor: 12.969

10.  Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.

Authors:  Daniel Dindo; Nicolas Demartines; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

View more
  16 in total

Review 1.  Hemostasis and Liver Regeneration.

Authors:  Patrick Starlinger; James P Luyendyk; Dafna J Groeneveld
Journal:  Semin Thromb Hemost       Date:  2020-09-09       Impact factor: 4.180

2.  Liver venous deprivation versus portal vein embolization before major hepatectomy: future liver remnant volumetric and functional changes.

Authors:  Boris Guiu; François Quenet; Fabrizio Panaro; Lauranne Piron; Christophe Cassinotto; Astrid Herrerro; François-Régis Souche; Margaux Hermida; Marie-Ange Pierredon-Foulongne; Ali Belgour; Serge Aho-Glele; Emmanuel Deshayes
Journal:  Hepatobiliary Surg Nutr       Date:  2020-10       Impact factor: 7.293

3.  Surgery is the means of treatment, but high-quality survival is the ultimate goal.

Authors:  Penglei Ge; Yang Wu
Journal:  Hepatobiliary Surg Nutr       Date:  2022-04       Impact factor: 7.293

Review 4.  Optimization of the future remnant liver: review of the current strategies in Europe.

Authors:  Riccardo Memeo; Maria Conticchio; Emmanuel Deshayes; Silvio Nadalin; Astrid Herrero; Boris Guiu; Fabrizio Panaro
Journal:  Hepatobiliary Surg Nutr       Date:  2021-06       Impact factor: 7.293

Review 5.  Issues to be considered to address the future liver remnant prior to major hepatectomy.

Authors:  Yoji Kishi; Jean-Nicolas Vauthey
Journal:  Surg Today       Date:  2020-09-07       Impact factor: 2.549

6.  Optimizing future remnant liver prior to major hepatectomies: increasing volume while decreasing morbidity and mortality.

Authors:  Hoylan Fernandez; Silvio Nadalin; Giuliano Testa
Journal:  Hepatobiliary Surg Nutr       Date:  2020-04       Impact factor: 7.293

7.  Portal vein embolization, biembolization, and liver venous deprivation.

Authors:  José Hugo Mendes Luz; Tiago Bilhim
Journal:  Radiol Bras       Date:  2021 May-Jun

8.  99mTc-mebrofenin hepatobiliary scintigraphy and volume metrics before liver preparation: correlations and discrepancies in non-cirrhotic patients.

Authors:  Boris Guiu; Emmanuel Deshayes; Fabrizio Panaro; Florian Sanglier; Caterina Cusumano; Astrid Herrerro; Olivia Sgarbura; Nicolas Molinari; François Quenet; Christophe Cassinotto
Journal:  Ann Transl Med       Date:  2021-05

9.  Ligation of the middle hepatic vein to increase hypertrophy induction during the ALPPS procedure.

Authors:  F Dondorf; A Ali Deeb; A Bauschke; P Felgendreff; H M Tautenhahn; M Ardelt; U Settmacher; F Rauchfuss
Journal:  Langenbecks Arch Surg       Date:  2021-05-10       Impact factor: 3.445

10.  Muscularity Defined by the Combination of Muscle Quantity and Quality is Closely Related to Both Liver Hypertrophy and Postoperative Outcomes Following Portal Vein Embolization in Cancer Patients.

Authors:  Siyuan Yao; Naoko Kamo; Kojiro Taura; Yosuke Miyachi; Sena Iwamura; Masaaki Hirata; Toshimi Kaido; Shinji Uemoto
Journal:  Ann Surg Oncol       Date:  2021-07-31       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.